Which has grown faster, IMTX or PCRX?

Over the past five years, PCRX grew revenue faster — IMTX at a 6.40% CAGR versus PCRX at 8.20%.

Is IMTX or PCRX more profitable?

PCRX runs the higher net margin — IMTX at -493.26% versus PCRX at 1.96%.

How have IMTX and PCRX total returns compared?

Over the past 5 years, IMTX delivered -9.88% and PCRX delivered -12.27% annualized total return. Past performance doesn't predict future results.

Immatics N.V. (IMTX) vs Pacira BioSciences, Inc. (PCRX)

A side-by-side comparison of Immatics N.V. and Pacira BioSciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

IMTX

Immatics N.V.

$1.02B

$7.64HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

PCRX

Pacira BioSciences, Inc.

$976M

$24.82HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

Total return — IMTX vs PCRX

growth of $100 · dividends reinvested · last 8y

IMTX -19.5% (-2.7%/yr)PCRX -46.7% (-7.6%/yr)IMTX compounded faster over this window

IMTX PCRX

IMTX vs PCRX: by the numbers

•IMTX is the larger company ($1.02B vs $976M market cap).
•PCRX is profitable (1.96% net margin) while IMTX runs a net loss (-493.26%).
•PCRX grew revenue faster over the past five years (8.20% vs 6.40% CAGR).

Metrics side by side

Valuation

Metric	IMTX	PCRX
P/E ratio	N/A	70.65
P/S ratio	21.10	1.31
P/B ratio	2.24	1.45
EV / EBITDA	N/A	11.41
FCF yield	N/A	18.39%

Profitability

Metric	IMTX	PCRX
Gross margin	100.00%	79.21%
Operating margin	-377.11%	2.47%
Net margin	-493.26%	1.96%
ROE	-52.47%	2.18%
ROIC	-53.36%	1.35%

Growth (annualized)

Metric	IMTX	PCRX
Revenue CAGR (5Y)	6.40%	8.20%
EPS CAGR (5Y)	N/A	-45.77%
FCF CAGR (5Y)	N/A	16.72%
Total return CAGR (5Y)	-9.88%	-12.27%

Frequently asked

Which has grown faster, IMTX or PCRX?: Over the past five years, PCRX grew revenue faster — IMTX at a 6.40% CAGR versus PCRX at 8.20%.
Is IMTX or PCRX more profitable?: PCRX runs the higher net margin — IMTX at -493.26% versus PCRX at 1.96%.
How have IMTX and PCRX total returns compared?: Over the past 5 years, IMTX delivered -9.88% and PCRX delivered -12.27% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IMTX analysis Full PCRX analysis Interactive comparison tool

Dig into the metrics

Pacira BioSciences P/E ratio Immatics ROE Pacira BioSciences ROE Immatics operating margin Pacira BioSciences operating margin Immatics revenue growth Pacira BioSciences revenue growth Immatics free cash flow Pacira BioSciences free cash flow

Immatics & Pacira BioSciences appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.